Effect of Pioglitazone on Inflammation in Cystic Fibrosis
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of pioglitazone on reducing airway
inflammation in cystic fibrosis and characterize the amount and timecourse of pioglitazone
elimination from the body.